Improvement of Nutrition Status and Digestive Conditions by Using Oral Nutritional Supplementation on Children in Vietnam

Undernutrition Clinical Trial

Official title:

Study the Efficiency of Oral Nutritional Supplementation on Anthropometric Indicators (Weight, Height), Nutrition Status, Digestive Disorders (Diarrhea, Constipation), and Anorexic in Children Between 24 - 71 Months Old.

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05551637
• Other study ID #: KAZUGOLD-NIN 176
• Status: Enrolling by invitation
• Phase: N/A
• Start date: August 1, 2022
• Est. completion date: August 1, 2023

Study information

• Verified date: September 2022
• Source: National Institute of Nutrition, Vietnam
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluating the efficiency of using Oral Nutritional Supplementation toward nutrition status (anthropometric index, the prevalence of wasting), digestive disorders, and anorexic in children aged 24 - 71 months.

Description:

Evaluating the efficiency of using Oral Nutritional Supplementation toward the improvement of the anthropometric index (weight, height, weight for age Z-score, height for age Z-score, and weight for height Z-score ), nutrition status (the prevalence of wasting) in children aged 24

• 71 months after 3 months using the nutrient product.

Evaluating the efficiency of using Oral Nutritional Supplementation for digestive disorders and anorexic in children aged 24 - 71 months.

The research involves a randomized controlled clinical trial (RCT). The plan is expected to conduct from 2022 to 2023 with over 600 children aged 24-71 months. The nutrient product produces a high amount of energy that provides over 472kcal/100g; 15,6g/100g of protein; 20,8g/100 of fat; 55,6g/100g of carbonhydrate; 338mg/100g of alpha-Linolenic acid; 1800mg/100g of Linoleic acid; 19,7mg/100g of 2'FL HMO; 1088mg/100g of MCT; 2700mg/100g of FOS/Inulin; 55mg/100g of GOS; 1000mg/100g of Lysine; 687mg/100g of Calcium; 68mg/100g of Magnesium; 6,5mg/100g of Iron; 3,6/100g of Zinc; 41,9µg/100g of Manganese; 2176IU/100g of Vitamin A; 376 IU/100g of Vitamin D3; 44µg/100g of Vitamin K1; 820µg/100g of Vitamin B1; 900µg/100g of Vitamin B2; 610µg/100g of Vitamin B6; 1,92µg/100g Vitamin B12; 4140µg/100g of Acid Pantothenic; 115µg/100g of Acid Folic; 98,2 grams of the product, which equals 2 packs (230ml x 2 per day) will supply about 36,4% - 48,1% of the required energy for children aged 2-5 years old. Additional components include Alpha-Linolenic Acid, which provides 67% of the recommended dietary allowances (RDAs), Linolenic Acid 60, which provides 90% RDAs, and 25 other micronutrients and minerals that include some essential vitamins such as Calcium 112-114% RDAs, Iron 118-120.4% RDAs, Vitamin A 145-174% RDAs, Zinc 75-87% RDAs, Vitamin D3 62% RDAs, Seleni 53-63% RDAs, Vitamin K 63-73% RDAs, Folic Acid 76-115% RDAs. With other elements such as 2'FL HMO (19,7 mg), FOS/inulin (2700 mg), Choline ( 47 mg, Taurine 20 mg) , multi medium-chain triglyceride (MCT) (1088 mg), Bifidobacterium longum (109 CFU). The study will be conducted at schools and homes: 600 children erratically divided into 2 groups, 1 group will use the product for 3 months ( with the amount of use: twice per day, 49,2 grams each time). The product will be distributed to the students through the schools. Monitoring will be performed carefully by the commune and district Health Department and the Centers for Disease Control and Prevention weekly. The study aims to evaluate the efficiency of nutrient products toward nutrition status ( anthropometric index, the prevalence of wasting), digestive disorders, and anorexic in children aged 24-71 months.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 600
• Est. completion date: August 1, 2023
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 24 Months to 71 Months

Eligibility

Inclusion Criteria:

• Children between the age of 24 - 71 months old that currently study in 10 preschools in the area of 10 selected communes.

• The family volunteered for the child to participate in the study

• Currently residing at 10 selected communes (over 1 year of residing)

• Z-score WHZ/BAZ < - 0.5

Exclusion Criteria:

• Lactose intolerance

• Children with a history of allergies, congenital diseases

• Intellectual disability or are suffering from acute and chronic infectious diseases

Related Conditions & MeSH terms

• Cachexia
• Malnourished
• Malnutrition
• Undernutrition
• Wasting

Intervention

Dietary Supplement:
• Kazu Gain Gold
Kazu Gain Gold is an Oral Nutritional Supplementation made by AIWAIDO Food Joint Stock Company. Condition: Powder Color: White to light yellow Scent: The fresh scent of milk, gracious sugary smell. Date of use: 24 months from the manufactured date. User Manual: Mix 6 spoons of Kazu Gain Gold (equal to 49,2 grams) with 180 ml of warm water (The energy density reaches 1kal/ml). Consume 2 glasses per day or follow the directions from the medical staff. The product should consume less than 1 hour. Do not let the child eat the leftovers of the previous meal. Preserve: Store in a clean, dry place, and keep away from direct sunlight. Opened can or package must be closed and used up within 3 weeks.

Locations

Country	Name	City	State
Vietnam	Yen Bai Province Obstetrics and Children's Hospital	Yen Bai

Sponsors (1)

Lead Sponsor	Collaborator
Tu Nguyen Song

Country where clinical trial is conducted

Vietnam, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Changes in the risk of wasting and malnutrition	Changes in the risk of wasting and malnutrition after 1, 2 and 3 months of intervention	over 1 and 3 months
Other	The change in the rate of wasting and malnutrition	The change in the rate of wasting and malnutrition after 1, 2, and 3 months of intervention	over 1 and 3 months
Primary	Improvement of anthropometric indicators and nutrient status (wasting)	Children in the intervention group will have more improvement with the anthropometric indicators (weight, height) than children in control group	Up to 3 months of intervention
Primary	Improvement of digestive disorders and anorexia nervosa	Children in intervention group will have more improvement in the digestive disorders and anorexic than children control group	From date of using the product until the date of first documented improvement, assessed up to 3 months
Secondary	Body Mass Index, i.e. changes of Body Mass Index (BMI)	Weight is measured in kg with one decimal value by the Body composition analyzer TANITA scale. The scale is checked and adjusted before use. Children wear light clothing, remove shoes and sandals, and sit or lie balanced, at the center of the scale. As soon as the balance is stable, read and write the result in kg and an odd number after the comma.; A wooden stadiometer measures height by precisely 0.1cm. Children stand up straight, their eyes look straight, and the top of their head touches the wooden shelf fixed at a 0 cm position. The child's whole body ensures that 9 points touch the surface of the ruler: occipital, shoulder blade, buttocks, calf, and heel. The result is recorded in cm and an odd number after the comma.; All data will be measured at the time T0 (at baseline) and T3 (after 3 months)	over 1 and 3 months
Secondary	Change of weight for age Z-score	Change of average weight for age Z Score and the difference between before intervention and after the intervention	over 1 and 3 months
Secondary	Change of weight for height Z-score	Change of average weight for height Z Score and the difference between before intervention and after the intervention	over 1 and 3 months
Secondary	Change of height for age Z-score	Change of average height for age Z Score and the difference between before intervention and after the intervention	over 1 and 3 months
Secondary	Changes in the rate of children have anorexia or gastrointestinal diseases	Changes in the percentage of anorexia, the incidence of gastrointestinal diseases (diarrhea, constipation), and anorexia above after intervention	over 1 and 3 months

External Links

•   Click here for more information about the organization in which this study is conducted. The Division of Planning is responsible to plan and implement the project.